Remove Operations Remove Pharmaceuticals Remove Process Improvement Remove Strategy
article thumbnail

How Chinese Companies Disrupt Through Business Model Innovation

Harvard Business

We in the West have long prided ourselves on our business process acumen, strategy savvy, and customer centricity while stereotyping Chinese competition as being nothing more than low cost. As a result, we have missed China’s transition from displacer to disruptor. This presents Western companies with a fresh challenge.

Company 31
article thumbnail

Change Management Is Becoming Increasingly Data-Driven. Companies Aren’t Ready

Harvard Business

This is giving us the opportunity to experiment with different change strategies within chosen populations in the company. In a project for a pharmaceutical company, we were able to isolate the specific information sources that drove positive and negative sentiment toward the client’s brand. Which stakeholders are involved?

article thumbnail

What a Changing NAFTA Could Mean for Doing Business in Mexico

Harvard Business

Multinational companies operating in Mexico are facing a great deal of uncertainty. With the confirmation of Robert Lighthizer as United States trade representative, the long-delayed start of the formal process to begin renegotiation of NAFTA with Canada and Mexico can move forward. Congress of its intent to begin the process.